Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smart foot device retrain walking after hemiplegia?

NCT ID NCT07754773

Disease control Sponsor: MultiCare Health System Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study tests whether a home-use device called the Motus Nova Foot can improve walking and balance in people aged 12-20 with hemiplegia, a condition where one side of the body is weak. The device moves the ankle and foot while guiding users through video activities, and it tracks how often it's used. Researchers will measure changes in heel strike, foot clearance, muscle activity, and balance using motion capture and other sensors. The goal is to see if this device can help reduce limping and improve overall gait.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Motus Nova Foot device
What this could lead to
If effective, this home-based device could offer a convenient way to improve walking and balance for people with hemiplegia, reducing the need for frequent clinic visits.
What could go wrong
This is a very small early-stage study (5 participants), so results may not apply broadly. The device may not produce lasting improvements, and individual responses could vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 5 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 20 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 12-20 years. * Diagnosis consistent with hemiplegia and gait/balance impairments involving ankle/foot control (e.g., reduced heel strike). * Able to ambulate and safely participate in laboratory walking and balance testing. * Able to follow instructions and use the Motus Nova Foot system at home with family support as needed. * Willingness to refrain from standard clinic-based PT during the study period. Exclusion Criteria: * Skin integrity issues or hypersensitivity preventing safe use of straps/pads. * Medical/orthopedic conditions making walking or balance testing unsafe (e.g., unstable seizures, recent surgery, acute injury). * Inability to safely use the device as determined during fitting/training. * Planned participation in standard clinic-based PT during the study period. * Electrical stimulation device to lower extremity within 6 months of study start, or planned use of electrical stimulation to lower extremity during study period. * Heart conditions that prevent physical activity. * Pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy cerebral palsy spastic hemiplegic hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral palsy Hemiplegia Hemiplegic cerebral palsy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mary Bridge Children's Therapy Research & Movement Lab

    Puyallup, Washington, 98372, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.